LifeWatch AG

EQS-Adhoc: LifeWatch AG: LifeWatch publishes results of Annual General Meeting


EQS Group-Ad-hoc: LifeWatch AG / Key word(s): AGM/EGM
LifeWatch AG: LifeWatch publishes results of Annual General Meeting

26-Apr-2017 / 14:34 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 KR
--------------------------------------------------------------------------------
LifeWatch publishes results of Annual General Meeting

Zug/Switzerland, April 26, 2017 - LifeWatch AG (SIX Swiss Exchange: LIFE), a
leading developer and provider of medical solutions and remote diagnostic
monitoring services in the digital health market, publishes the results of
today's Annual General Meeting. Fifty-one shareholders attended the meeting in
Zurich and approximately 11,262,000 votes or 60.95% of the share capital were
represented. The outcome of the motions are summarized below:
Approval of the Annual Report 2016 and the allocation of the balance sheet
result 2016.Discharge for fiscal year 2016 was granted to Dr. Robert Bider,
Antoine Kohler, Raymond W. Cohen, Jinsheng Dong, Antoine Hubert, Thomas Rühle,
Patrick Schildknecht, Dr. Stephan Rietiker, Dr. Christoph Heinzen, Stephanie
Kravetz, Andrew Moore, Michael Turchi and Stefan Vogt.Elections to the Board of
Directors until the next Ordinary Annual General Meeting 2018Dr. Robert Bider,
Raymond W. Cohen, Thomas Rühle and Patrick Schildknecht were re-elected.As
recommended by Erhard Lee, representative of AMG Analysen & Anlagen, Markus
Breitenmoser was newly elected as a member of the Board.Xu Shenlu, recommended
by Jinsheng Dong, representative of Himalaya TMT Funds, was not elected as a new
member of the Board.Dr. Robert Bider was re-elected as Chairman of the Board of
Directors.Elected as members of the Compensation Committee: Thomas Rühle and
Raymond W. Cohen.The Annual General Meeting did not approve the proposed
amendments to the Articles of Incorporation on the introduction of Article 3bis
(conditional capital).The Annual General Meeting approved the total compensation
to be paid to the Board of Directors for the financial year 2018 in the maximum
amount of CHF 700,000.The Annual General Meeting did not approve the proposed
fixed compensation for the Executive Management Team for the financial year 2018
in the maximum amount of CHF 2,100,000. In a second vote, the Annual General
Meeting did approve the proposed fixed compensation for the Executive Management
Team for the financial year 2018 in the maximum amount of CHF 1,900,000.The
Annual General Meeting approved the proposed variable compensation for the
Executive Management Team for the financial year 2016 of the maximum amount of
CHF 0.Re-election of the independent proxy: Yves Endrass, ZurichRe-election of
the statutory auditors: PricewaterhouseCoopers, Zurich

For further questions:
LifeWatch AG, Andrew Moore, CFO
c/o Communicators AG , Ralph Spillmann
Mobile: +41 79 514 64 84
E-Mail: investor-relations@lifewatch.com

About LifeWatch AG

LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE),
Switzerland, is a leading healthcare technology and solution company,
specializing in advanced digital health systems and wireless remote diagnostic
patient monitoring services. LifeWatch's services provide physicians with
critical information to determine appropriate treatment and thereby improve
patient outcomes. LifeWatch AG has operative subsidiaries in the United States,
in Switzerland, Israel and Turkey, and is the parent company of LifeWatch
Services Inc., LifeWatch Technologies, Ltd. and LifeWatch Turkey Holding AG
(joint venture). LifeWatch Services, Inc. is a leading U.S.-based provider of
cardiac monitoring services. LifeWatch Technologies Ltd., based in Israel, is a
leading manufacturer of digital health products. LifeWatch Sağlık Hizmetlerine
A.S. is the operative Turkish subsidiary of LifeWatch Turkey Holding AG and
provider of mobile cardiac telemetry services in Turkey. For additional
information, please visitwww.lifewatch.com.

Sign up for customized e-mail alerts and documentation requests at
https://www.lifewatch.com/Investor-Relations/Alert-Service.html

This press release includes forward-looking statements. All statements other
than statements of historical facts contained in this press release, including
statements regarding future results of operations and financial position, the
business strategy, and plans and objectives for future operations, are
forward-looking statements. The words "believe," "may," "will," "estimate,"
"continue," "anticipate," "intend," "expect" and similar expressions are
intended to identify forward-looking statements. LifeWatch AG has based these
forward-looking statements largely on current expectations and projections about
future events and financial trends that it believes may affect the financial
condition, results of operations, business strategy, short-term and long-term
business operations and objectives, and financial needs. These forward-looking
statements are subject to a number of risks, uncertainties and assumptions. In
light of these risks, uncertainties and assumptions, the forward-looking events
and circumstances described may not occur and actual results could differ
materially and adversely from those anticipated or implied in the
forward-looking statements. All forward-looking statements are based only on
data available to LifeWatch AG at the time of the issue of this press release.
LifeWatch AG does not undertake any obligation to update any forward-looking
statements contained in this press release as a result of new information,
future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND MUST
NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A GENERAL
CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN
OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE
UNITED STATES, OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF
LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE
SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER
THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED
WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT FROM REGISTRATION UNDER OR AN
APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES
SECURITIES LAWS.

Additional features:


Document:http://n.eqs.com/c/fncls.ssp?u=QXQUVCFJEL
Document title: 20170426_Outcome AGM_EN
--------------------------------------------------------------------------------
End of ad hoc announcement------------------------------------------------------

Language: English

Company:  LifeWatch AG

          Baarerstrasse 139

          6300 Zug

          Switzerland

Phone:    +41 41 728 67 78

Internet: www.lifewatch.com

ISIN:     CH0012815459

Valor:    811189

Listed:   Regulated Unofficial Market in Berlin, Stuttgart; Open Market in
Frankfurt; SIX Swiss Exchange



 

End of Announcement EQS Group News Service

--------------------------------------------------------------------------------

567691  26-Apr-2017 CET/CEST
 



Weitere Meldungen: LifeWatch AG

Das könnte Sie auch interessieren: